Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Strategic Partners ASCHIX:STRAPC 25 3-Year EPS without NRI Growth Rate is 73.30% as of Jun. 2026, which is 44% above its 10-year median of 50.90. GuruFocus rates CHIX:STRAPC with a GF Score™ of 25/100. The stock has 2 warning signs investors should review. Among 1,161 Biotechnology companies, Strategic Partners AS ranks better than 93.8% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 73.30% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 78.60% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 47.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 12 years, the highest 3-Year average EPS without NRI Growth Rate of Strategic Partners AS was 86.30% per year. The lowest was -41.50% per year. And the median was 50.90% per year.
Strategic Partners AS (CHIX:STRAPc) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Strategic Partners AS 3-Year EPS without NRI Growth Rate Related Terms
CHIX:STRAPC vs VRTX, REGN, RVMD: 3-Year EPS without NRI Growth Rate Comparison
For the Biotechnology subindustry, Strategic Partners AS's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strategic Partners AS 3-Year EPS without NRI Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Strategic Partners AS's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Strategic Partners AS's 3-Year EPS without NRI Growth Rate falls into.
Strategic Partners AS 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 73.30% mean?
Strategic Partners AS (CHIX:STRAPC) has a 3-Year EPS without NRI Growth Rate of 73.30% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Strategic Partners AS and its competitors. This is 44% above median its historical median of 50.90. According to the industry distribution chart, Strategic Partners AS ranks #72 out of 1161 companies in the Biotechnology industry, placing it in the top 6.2%.
Is Strategic Partners AS's 3-Year EPS without NRI Growth Rate too high?
Strategic Partners AS's current 3-Year EPS without NRI Growth Rate of 73.30% is 44% above median its 10-year median of 50.90. The Biotechnology industry median 3-Year EPS without NRI Growth Rate is 16.20. Strategic Partners AS's value of 73.30% is 352.5% above this industry median. Based on the distribution chart, Strategic Partners AS ranks #72 out of 1161 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Strategic Partners AS has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Strategic Partners AS's 3-Year EPS without NRI Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Strategic Partners AS ranks #72 out of 1161 companies for 3-Year EPS without NRI Growth Rate. This places Strategic Partners AS in the top 6% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 16.20. Strategic Partners AS's value of 73.30% is 352.5% above this benchmark. While the company's 10-year median is 50.90 vs. the industry median of 16.20, Strategic Partners AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Biotechnology company?
The median 3-Year EPS without NRI Growth Rate among Biotechnology companies is 16.20, based on 1,161 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Strategic Partners AS's current 3-Year EPS without NRI Growth Rate of 73.30% is 352.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Strategic Partners AS and its competitors. For the Biotechnology industry, the median 3-Year EPS without NRI Growth Rate is 16.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strategic Partners AS's current 3-Year EPS without NRI Growth Rate is 73.30%, which is 44% above median its own 10-year median of 50.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strategic Partners AS stock overvalued right now?
Strategic Partners AS (CHIX:STRAPC) has a current 3-Year EPS without NRI Growth Rate of 73.30%. The current 3-Year EPS without NRI Growth Rate is 73.30%, which is 44% above median its 10-year median of 50.90 and 352.5% above the Biotechnology industry median of 16.20. Strategic Partners AS's overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Strategic Partners AS (CHIX:STRAPC), the current 3-Year EPS without NRI Growth Rate is 73.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Strategic Partners A/S enters into strategic partnerships with companies with potential, where the company can take an active ownership and create value through its competencies. Additionally, the company takes part in other equity investments and properties, etc., to generate returns.
25GF Score
Get the complete analysis for CHIX:STRAPC
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:STRAPC has been successfully added to your 
